Publication | Closed Access
Effects of Pyridoxamine in Combined Phase 2 Studies of Patients with Type 1 and Type 2 Diabetes and Overt Nephropathy
240
Citations
25
References
2007
Year
These data provide a foundation for further evaluation of this AGE inhibitor in DN.
| Year | Citations | |
|---|---|---|
Page 1
Page 1